{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:11:25Z","timestamp":1771333885412,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejogrb.2021.08.008","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T01:37:03Z","timestamp":1628473023000},"page":"39-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Rate of hourly change in serum beta-human chorionic gonadotropin levels in ectopic pregnancy can predict the success of treatment with single-dose methotrexate: A retrospective observational study"],"prefix":"10.1016","volume":"265","author":[{"given":"G.","family":"Lavie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Tendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Marwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sharon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2021.08.008_b0005","unstructured":"Centers for Disease Control and Prevention (CDC). Ectopic pregnancy--United States, 1990-1992. MMWR Morb Mortal Wkly Rep 1995; 44: 46\u20138. PMID 7823895."},{"issue":"6","key":"10.1016\/j.ejogrb.2021.08.008_b0010","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"5, Part 1","key":"10.1016\/j.ejogrb.2021.08.008_b0015","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/01.AOG.0000158860.26939.2d","article-title":"Ectopic pregnancy rate and treatment utilization in a large managed care organization","volume":"105","author":"Van Den Eeden","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.08.008_b0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.fertnstert.2006.10.007","article-title":"Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review","volume":"87","author":"Menon","year":"2007","journal-title":"Fertil Steril"},{"issue":"14","key":"10.1016\/j.ejogrb.2021.08.008_b0025","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1080\/14767058.2018.1551353","article-title":"Day 1 change in maternal serum \u03b2-HCG levels as an early predictor of successful medical therapy in ectopic pregnancies","volume":"33","author":"Ahmed","year":"2020","journal-title":"J Matern Fetal Neonat Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.008_b0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/rmb2.12247","article-title":"Human chorionic gonadotropin value and its change prior to methotrexate treatment can predict the prognosis in ectopic tubal pregnancies","volume":"18","author":"Watanabe","year":"2019","journal-title":"Reprod Med Biol"},{"key":"10.1016\/j.ejogrb.2021.08.008_b0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00404-008-0589-4","article-title":"Increment in beta-hCG in the 48-h period prior to treatment: a new variable predictive of therapeutic success in the treatment of ectopic pregnancy with methotrexate","volume":"278","author":"Da Costa","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2021.08.008_b0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejogrb.2017.02.007","article-title":"The role of HCG increment in the 48 h prior to methotrexate treatment as a predictor for treatment success","volume":"211","author":"Cohen","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.08.008_b0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ijgo.12395","article-title":"Predicting success of methotrexate treatment by pretreatment HCG level and 24-hour HCG increment","volume":"141","author":"Levin","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2021.08.008_b0050","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/0002-9378(93)90687-E","article-title":"Single-dose methotrexate: an expanded clinical trial","volume":"168","author":"Stovall","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2021.08.008_b0055","doi-asserted-by":"crossref","unstructured":"E. Kirk G. Condous B. Van Calster Z. Haider S. Van Huffel D. Timmerman et al. A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy 22 3 2007 2007 2007 858 863 10.1093\/humrep\/del433","DOI":"10.1093\/humrep\/del433"},{"key":"10.1016\/j.ejogrb.2021.08.008_b0060","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 94: Medical management of ectopic pregnancy. American College of Obstetricians and Gynecologists. Obstet Gynecol 2008; 111: 1479-85. doi: 10.1097\/AOG.0b013e31817d201e, PMID 18515537.","DOI":"10.1097\/AOG.0b013e31817d201e"},{"key":"10.1016\/j.ejogrb.2021.08.008_b0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.fertnstert.2013.06.013","article-title":"Medical treatment of ectopic pregnancy: a committee opinion","volume":"100","author":"Practice Committee of American Society for Reproductive Medicine","year":"2013","journal-title":"Fertil Steril"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521004085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521004085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:53:27Z","timestamp":1759557207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521004085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":13,"alternative-id":["S0301211521004085"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.08.008","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rate of hourly change in serum beta-human chorionic gonadotropin levels in ectopic pregnancy can predict the success of treatment with single-dose methotrexate: A retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}